Genflow Biosciences Plc Overview
Get informed when a big investor buys or sells
+ Follow199.75%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, GENF.L shows a ROE of 199.75%. That is above the Healthcare sector average of -75.84%. Scroll down for historical charts and peer comparison views.
The Healthcare sector average ROE is about -75.84%. Genflow Biosciences Plc is at 199.75%, which is higher that average. That is roughly 363.4% above the sector mean. Use the comparison chart on this page to see how GENF.L stacks up against individual peers as well.
Check the historical chart to see whether GENF.L's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Genflow Biosciences Plc with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Genflow Biosciences Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 199.75%) with ownership activity and broader fundamentals.
The Healthcare average ROE is about -75.84%, while GENF.L is at 199.75%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
